Analysts Set Elevance Health, Inc. (NYSE:ELV) PT at $498.87
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given an average recommendation of “Moderate Buy” by the sixteen analysts that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 1-year price […]
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given an average recommendation of “Moderate Buy” by the sixteen analysts that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 1-year price […]
